PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $275,783 | -53.8% | 6,781 | -44.9% | 0.01% | -57.1% |
Q1 2023 | $596,635 | +129.7% | 12,317 | +81.0% | 0.01% | +100.0% |
Q4 2022 | $259,747 | -26.6% | 6,805 | -3.5% | 0.01% | -36.4% |
Q3 2022 | $354,000 | +34.1% | 7,055 | +6.9% | 0.01% | +37.5% |
Q2 2022 | $264,000 | +30.7% | 6,599 | +37.9% | 0.01% | -11.1% |
Q2 2021 | $202,000 | -11.0% | 4,785 | 0.0% | 0.01% | -10.0% |
Q1 2021 | $227,000 | -22.3% | 4,785 | -0.0% | 0.01% | 0.0% |
Q4 2020 | $292,000 | +22.2% | 4,786 | -6.5% | 0.01% | +25.0% |
Q3 2020 | $239,000 | -8.1% | 5,119 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $260,000 | +12.6% | 5,119 | -1.0% | 0.01% | +33.3% |
Q1 2020 | $231,000 | -6.5% | 5,170 | +0.7% | 0.01% | +20.0% |
Q4 2019 | $247,000 | +6.9% | 5,133 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $231,000 | -39.2% | 5,133 | -53.7% | 0.00% | -33.3% |
Q4 2018 | $380,000 | -37.0% | 11,079 | -13.7% | 0.01% | -25.0% |
Q3 2018 | $603,000 | +47.1% | 12,840 | +5.7% | 0.01% | +33.3% |
Q2 2018 | $410,000 | +3.5% | 12,151 | -38.6% | 0.01% | 0.0% |
Q3 2017 | $396,000 | – | 19,796 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
RA Capital Management | 300,000 | $6,438,000 | 0.67% |
Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |